BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23071609)

  • 1. Measles virus glycoprotein-based lentiviral targeting vectors that avoid neutralizing antibodies.
    Kneissl S; Abel T; Rasbach A; Brynza J; Schneider-Schaulies J; Buchholz CJ
    PLoS One; 2012; 7(10):e46667. PubMed ID: 23071609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral vectors displaying modified measles virus gp overcome pre-existing immunity in in vivo-like transduction of human T and B cells.
    Lévy C; Amirache F; Costa C; Frecha C; Muller CP; Kweder H; Buckland R; Cosset FL; Verhoeyen E
    Mol Ther; 2012 Sep; 20(9):1699-712. PubMed ID: 22617109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles virus glycoprotein-pseudotyped lentiviral vector-mediated gene transfer into quiescent lymphocytes requires binding to both SLAM and CD46 entry receptors.
    Frecha C; Lévy C; Costa C; Nègre D; Amirache F; Buckland R; Russell SJ; Cosset FL; Verhoeyen E
    J Virol; 2011 Jun; 85(12):5975-85. PubMed ID: 21450813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retargeting vesicular stomatitis virus using measles virus envelope glycoproteins.
    Ayala-Breton C; Barber GN; Russell SJ; Peng KW
    Hum Gene Ther; 2012 May; 23(5):484-91. PubMed ID: 22171635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted cell entry of lentiviral vectors.
    Funke S; Maisner A; Mühlebach MD; Koehl U; Grez M; Cattaneo R; Cichutek K; Buchholz CJ
    Mol Ther; 2008 Aug; 16(8):1427-36. PubMed ID: 18578012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells.
    Humbert JM; Frecha C; Amirache Bouafia F; N'Guyen TH; Boni S; Cosset FL; Verhoeyen E; Halary F
    J Virol; 2012 May; 86(9):5192-203. PubMed ID: 22345444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DARPins: an efficient targeting domain for lentiviral vectors.
    Münch RC; Mühlebach MD; Schaser T; Kneissl S; Jost C; Plückthun A; Cichutek K; Buchholz CJ
    Mol Ther; 2011 Apr; 19(4):686-93. PubMed ID: 21224833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted lentiviral vectors pseudotyped with the Tupaia paramyxovirus glycoproteins.
    Enkirch T; Kneissl S; Hoyler B; Ungerechts G; Stremmel W; Buchholz CJ; Springfeld C
    Gene Ther; 2013 Jan; 20(1):16-23. PubMed ID: 22218301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins.
    Frecha C; Costa C; Nègre D; Gauthier E; Russell SJ; Cosset FL; Verhoeyen E
    Blood; 2008 Dec; 112(13):4843-52. PubMed ID: 18812471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-specific targeting of lentiviral vectors mediated by fusion proteins derived from Sindbis virus, vesicular stomatitis virus, or avian sarcoma/leukosis virus.
    Zhang XY; Kutner RH; Bialkowska A; Marino MP; Klimstra WB; Reiser J
    Retrovirology; 2010 Jan; 7():3. PubMed ID: 20100344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting lymphocyte transduction with measles virus glycoprotein pseudotyped lentiviral vectors relies on CD46 and SLAM.
    Zhou Q; Schneider IC; Gallet M; Kneissl S; Buchholz CJ
    Virology; 2011 May; 413(2):149-52. PubMed ID: 21470651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
    Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
    J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies.
    Parker CL; Jacobs TM; Huckaby JT; Harit D; Lai SK
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins.
    Schoenhals M; Frecha C; Bruyer A; Caraux A; Veyrune JL; Jourdan M; Moreaux J; Cosset FL; Verhoeyen E; Klein B
    Leukemia; 2012 Jul; 26(7):1663-70. PubMed ID: 22318450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biophysical characterization and single-chain Fv construction of a neutralizing antibody to measles virus.
    Tadokoro T; Jahan ML; Ito Y; Tahara M; Chen S; Imai A; Sugimura N; Yoshida K; Saito M; Ose T; Hashiguchi T; Takeda M; Fukuhara H; Maenaka K
    FEBS J; 2020 Jan; 287(1):145-159. PubMed ID: 31287622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
    Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
    PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity.
    Funke S; Schneider IC; Glaser S; Mühlebach MD; Moritz T; Cattaneo R; Cichutek K; Buchholz CJ
    Gene Ther; 2009 May; 16(5):700-5. PubMed ID: 19212424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
    Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
    Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.